(Q28244389)
Statements
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (English)
Sandeep T Patil
Lu Zhang
Ferenc Martenyi
Stephen L Lowe
Kimberley A Jackson
Alla S Avedisova
Issak Y Gurovich
Nikolai G Neznanov
Alexander M Reznik
Vladimir A Tochilov
Bryan G Johnson
James A Monn
Darryle D Schoepp
Identifiers
2 references
2 references